Header Logo

Connection

CHARENYA ANANDAN to Humans

Back to Details
This is a "connection" page, showing publications CHARENYA ANANDAN has written about Humans.
CHARENYA ANANDAN
Connection Strength
0.107
Humans
  1. Botulinum toxin treatment in parkinsonism. J Neurol Sci. 2024 01 15; 456:122810.
    View in: PubMed
    Score: 0.024
  2. Botulinum Toxin in Movement Disorders: An Update. Toxins (Basel). 2021 Jan 08; 13(1).
    View in: PubMed
    Score: 0.020
  3. Intramuscular interstitial amyloid deposition does not impact anoctaminopathy-5 phenotype. Muscle Nerve. 2019 01; 59(1):133-137.
    View in: PubMed
    Score: 0.017
  4. Rhabdomyolysis and fluctuating asymptomatic hyperCKemia associated with CACNA1S variant. Eur J Neurol. 2018 02; 25(2):417-419.
    View in: PubMed
    Score: 0.016
  5. An adult with a rare form of congenital fiber type disproportion. Muscle Nerve. 2018 01; 57(1):E97-E99.
    View in: PubMed
    Score: 0.016
  6. Prevalence of autonomic dysfunction in hospitalized patients with Guillain-Barr? syndrome. Muscle Nerve. 2017 08; 56(2):331-333.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.